课题基金 / 基金详情

PYRIDINE NUCLEOTIDES--TURNOVER AND REGULATION

PYRIDINE NUCLEOTIDES--TURNOVER AND REGULATION
吡啶核苷酸——周转和调节
批准号:
3273190
负责人:
BALDOMERO M OLIVERA
金额:
$16.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-02-01 至 1994-04-30

项目摘要

项目成果

BALDOMERO M OLIVERA的其他基金

相似基金

相关文献

中文摘要
翻译
拟议的研究重点是吡啶核苷酸代谢, 特别是其中KNEED作为底物被消耗的反应 并且必须再生,从而产生吡啶核苷酸, 周期 KNEED分解的几个重要反应 是DNA相关的(即,细菌DNA连接,聚ADP- DNA拓扑异构酶的核糖基化)。 下一个赠款期的一些具体目标是:(1) 了解吡啶核苷酸代谢的调节, 鼠伤寒沙门氏菌 首先,全面 该途径阻遏物的生物化学表征将 执行。 (2)由于DNA连接似乎并不启动 细菌主要的吡啶核苷酸循环,代谢作用 沙门氏菌的循环将被调查。 (3)真核 吡啶核苷酸环,聚焦单ADP核糖基化 反应将被调查;这些研究将被执行 在脊椎动物神经组织上。 (4)Poly之间的关系 ADP-核糖基化和DNA连接在真核细胞中将是 研究了 吡啶核苷酸是所有细胞代谢的核心。 一个与医学相关的方面是,这种新陈代谢可能起着关键作用, 在致病菌和 吞噬细胞
英文摘要
The proposed research focuses on pyridine nucleotide metabolism, particularly reactions in which KNEED is consumed as a substrate and has to be regenerated, thereby generating a pyridine nucleotide cycle. Several important reactions in which KNEED is broken down are DNA related (i.e., bacterial DNA ligation, poly ADP- ribosylation of DNA topoisomerase). Some of the specific goals for the coming grant period are, (1) to understand regulation of pyridine nucleotide metabolism in the bacterium Salmonella typhimurium. Initially, a comprehensive biochemical characterization of the repressor for this pathway will be carried out. (2) Since DNA ligation does not appear to initiate the major bacterial pyridine nucleotide cycle, the metabolic role of the Salmonella cycle will be investigated. (3) Eukaryotic pyridine nucleotide cycles, focusing mono-ADP-ribosylation reactions will be investigated; these studies will e carried out on vertebrate neuronal tissue. (4) The relationship between poly ADP-ribosylation and DNA ligation in eukaryotic cells will be investigated. Pyridine nucleotides are central to the metabolism of all cells. One medically related facet is that this metabolism may play a key role ln the interactions between pathogenic bacteria and phagocytes.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Poly(ADP-ribosylation) of DNA topoisomerase I: a nuclear response to DNA-strand interruptions.
DNA 拓扑异构酶 I 的聚(ADP-核糖基化):对 DNA 链中断的核反应。
DOI: 10.1101/sqb.1984.049.01.077
发表时间: 1984
期刊: Cold Spring Harbor symposia on quantitative biology
影响因子: --
作者: [Ferro,AM, McElwain,MC, Olivera,BM]
通讯作者: Olivera,BM
Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus.
小牛胸腺 DNA 拓扑异构酶 I 的聚(ADP-核糖基化)。
DOI: --
发表时间: 1984
期刊: The Journal of biological chemistry
影响因子: --
作者: [Ferro,AM, Olivera,BM]
通讯作者: Olivera,BM
Poly (ADP-ribosylation) and DNA topoisomerase I in different cell lines.
不同细胞系中的多聚(ADP-核糖基化)和 DNA 拓扑异构酶 I。
DOI: 10.1007/978-1-4684-8730-5_45
发表时间: 1984
期刊: Advances in experimental medicine and biology
影响因子: --
作者: [Ferro,AM, Thompson,LH, Olivera,BM]
通讯作者: Olivera,BM
Poly(ADP-ribosylation) of a DNA topoisomerase.
DNA 拓扑异构酶的聚(ADP-核糖基化)。
DOI: --
发表时间: 1983
期刊: The Journal of biological chemistry
影响因子: --
作者: [Ferro,AM, Higgins,NP, Olivera,BM]
通讯作者: Olivera,BM
6
    “Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
    • 批准号:
      10592438
    • 项目类别:
    • 资助金额:
      $57.45万
    • 财政年份:
      2022
    • 负责人:
      BALDOMERO M OLIVERA
    • 依托单位:
    “Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
    • 批准号:
      10346236
    • 项目类别:
    • 资助金额:
      $57.32万
    • 财政年份:
      2022
    • 负责人:
      BALDOMERO M OLIVERA
    • 依托单位:
    “Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
    • 批准号:
      10798547
    • 项目类别:
    • 资助金额:
      $15.34万
    • 财政年份:
      2022
    • 负责人:
      BALDOMERO M OLIVERA
    • 依托单位:
    “Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
    • 批准号:
      10810172
    • 项目类别:
    • 资助金额:
      $1.08万
    • 财政年份:
      2022
    • 负责人:
      BALDOMERO M OLIVERA
    • 依托单位:
    海外基金